论文部分内容阅读
目的探讨黄芪、炎琥宁注射液治疗病毒性心肌炎的疗效。方法将53例病毒性心肌炎患儿随机分为治疗组与对照组,治疗组予以抗心律失常西药,黄芪、炎琥宁静脉滴注;对照组予抗心律失常西药,极化液静脉滴注,两组均以14d为一疗程,治疗后两组疗效进行比较。结果治疗组总有效率94.3%,对照组总有效率61.1%。结论治疗组疗效明显优于对照组(P<0.01),黄芪注射液和炎琥宁注射液静脉滴注治疗病毒性心肌炎,可缩短病程,改善心功能,提高机体抵抗力,是较为理想的抗病毒及细菌感染的中药制剂,可作为治疗病毒性心肌炎的主要药物。
Objective To investigate the curative effect of Astragalus and Yanhuning injection on viral myocarditis. Methods Fifty-three children with viral myocarditis were randomly divided into treatment group and control group. The treatment group was given anti-arrhythmic western medicine, Astragalus membranaceus and Yanhuoning intravenous drip. The control group was given anti-arrhythmic western medicine, Both groups were 14d for a course of treatment, after treatment, the two groups were compared. Results The total effective rate was 94.3% in the treatment group and 61.1% in the control group. Conclusions The curative effect of the treatment group is obviously better than that of the control group (P <0.01). Astragalus injection and Yanhuning injection intravenous drip treatment of viral myocarditis can shorten the course of disease, improve cardiac function and improve body resistance, which is an ideal anti-inflammatory Viral and bacterial infections of traditional Chinese medicine preparations, can be used as the main drug treatment of viral myocarditis.